Sabela Lens García

Hepatologist with special focus on Viral Hepatitis and the immune response. 'keep calm'. Tweets = my own.

[Uppy Gill @druppygill]

Great to have lead & contributed to this piece with @SaSi_Lens & @toryappleby focussing on changes in management of CHB, based on recent EASL guidelines-the field is evolving for HBV cure! Please have a read. @blizard_inst @BartsHepatology @QMULBartsTheLon @FrontGastro_BMJ

[EASL Education @EASLedu]

Is it time to rethink how we talk about #HCV reinfection in #PWID?🤔
Watch #EASLStudio TODAY for expert insights, real-world data & fresh perspectives.
📅Wednesday 24 Sempetember | 18:00 CEST
🔗https://t.co/z6HGJWvETy

@Aelsharkawy75 @Sasi_Lens @TatyanaKushner @HeinerWedemeyer @CornbergkMarkus @ThomasBerg24

[EASL Education @EASLedu]

High risk, high stakes. Today's #EASLStudio discusses #HCV in #PWID, reinfection, and the future of treatment frameworks. Do you see patients with Hepatitis C who return viraemic after cure?

📅Wednesday 24 September | 18:00 CEST
🔗 https://t.co/z6HGJWv740

@Aelsharkawy75 @Sasi_Lens @TatyanaKushner @HeinerWedemeyer @CornbergkMarkus @ThomasBerg24

[EASLnews @EASLnews]

🌍 At EASL, we are committed to building an inclusive community across our four pillars: Education, Advocacy, Science, and Leadership.

Our new Equity, Diversion, and Inclusion policy sets out:

✔️ Practical steps to remove barriers and promote fair representation
✔️ Procedures to address discrimination
✔️ Short- and long-term goals for lasting progress

We believe that diversity strengthens innovation, drives collaboration, and ensures liver health for all.

📢 We invite all stakeholders to review the policy and share feedback during the consultation phase, by 15 September.
https://t.co/Dq7LDU7Bzn

@DebbieShawcros1 @analleo @aelsharkawy75 @fprusso73 @SaSi_Lens @SagiZelber @PinterMatthias @RuiCastro @MajaThiele @bogdanprocopet @EmmaCulver6 @FrancqueSven

[IDIBAPS @idibaps]

Aquesta setmana...

Hepatòlogues del #CLÍNIC-#IDIBAPS participen en la renovació de les guies europees sobre hepatitis autoinmune i l’hepatitis B

👉https://t.co/rz5arbGEF0

[EASLnews @EASLnews]

🆕We are excited to announce the launch of the new Fellowship Programme!
Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease?
Discover our two fellowship types and apply by 1 September 2025!

🔗 https://t.co/dWRGj6ij2d

#LiverTwitter #LiverX

[EASLnews @EASLnews]

What are the latest and concrete recommendations for the clinical application of AI in hepatology?🤖

Read now this position paper from the EASL AI Task Force from @JHepatology: https://t.co/nHgZ31oWru

#LiverX #LiverTwitter

@JClusmann @C_V_Schneider @tpseraphin @tom_luedde @tom_marjot @AshleySpannMD @DebbieShawcros1 @SaSi_Lens @etrepo @jnkath

[TherVacB Project @TherVacB_EU]

🚨Just in time for #WorldHepatitisDay 2025: #TherVacB launches its clinical #trial for a curative vaccine strategy against chronic #HepatitisB.
#⃣ total 81 patients
🌐5 countries
🎯1 goal: a functional #cure
👉 https://t.co/SFuMt8TQig
#HepatitisCantWait #livertwitter @EU_Health

[EASLnews @EASLnews]

Are you interested in building the future of hepatology with us? Do you have a strong scientific track record in Immune-mediated and Cholestatic Diseases?

The EASL Scientific Committee is looking for one new member!

Read more and apply by 15 June 23:59 CEST on: https://t.co/ZIZE4QRo07

#LiverTwitter #LiverX

[EASLnews @EASLnews]

Join this week's #EASLStudio episode to explore how artificial intelligence is transforming healthcare 🤖
Our faculty @aelsharkawy75, @jnkath, @SaSi_Lens & @AshleySpannMD will discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession.

🗓️ This Wednesday, 4 June 18:00 CEST
🔗 https://t.co/OoHgVJdphY

#LiverTwitter #LiverX

[EASLnews @EASLnews]

Applications for the 2025 EASL- @AASLDtweets Masterclass in France on 4–6 December are now open!

2 days of intensive training with renowned leaders in hepatology & like-minded peers in the field 🔥

Read more & apply by 10 June: https://t.co/FvAfZy3dnu

@FrancqueSven @SaSi_Lens

#LiverTwitter #LiverX

[Grace Wong @wonglaihung]

Honoured to be part of the #EASL #HBV #CPG! 😊😊😊
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Free text here: https://t.co/YlgDQu7fYT
#EASLCongress

[EASL Education @EASLedu]

📢 The updated #HBV guidelines were just presented by @CornbergMarkus @ #EASLcongress.
✔️ Focus on shared decision-making
✔️ Simplified treatment algorithm
✔️ Clear answers to key questions:
👉Who to treat?
👉When to start?
👉What are the #HCC risk factors?
👉What if ALT is normal but HBV DNA is high?

@JHepatology @EASLnews
#LiverX

[Sabela Lens García @SaSi_Lens]

Thank you to the whole team x the amazing hospitality and dynamic clinical discussions!!! 🤩

[Sara Battistella @s_battistellaMD]

Such an honor to host @SaSi_Lens in Padua for an insightful talk on #HBV! 🧬💡 Great discussions, valuable learnings, and amazing moments together 🙌
@fprusso73 @MartinaGambato @GiacomoGermani1 @UniPadova

[EASLnews @EASLnews]

⏳Only 1 week left to submit your late-breaking Abstracts! ⏳

Got novel research in hepatology? Don't miss your chance to present it at #EASLCongress 2025 in Amsterdam! 🚀

📅 Deadline: 17 March
👉https://t.co/zL7bFr6qZr

@AleksanderKrag @DebbieShawcros1

[EASLnews @EASLnews]

📢 ¡Oferta exclusiva en @AEEHLiver 2025! 🎉

Visítanos en el stand de EASL en la zona comercial y obtén un 20% de descuento en tu membresía de EASL.
¡No pierdas esta oportunidad de unirte y mantenerte al día con lo último en hepatología!

Estamos aquí hasta mañana, viernes 28, así que pásate por nuestro stand para conocer nuestros próximos eventos y actividades. ¡Te esperamos! 👋

@Mariabutif @VirginiaHdezGea @SaSi_Lens @JesusMBanales @rabataller

[Asociación Española para el Estudio del Hígado @AEEHLiver]

🔝¡Hoy ha sido un día importante para el @hospitalclinic y varios compañeros de la #AEEH!
El centro ha recibido el Certificado de la AEEH a la Excelencia en la lucha contra la #hepatitisC. Ha recogido la distinción @SaSi_Lens de manos de @Alexfornergon. 💯
💊En los últimos años, la Unidad de Hepatitis del Clinic se ha involucrado en el proceso de eliminación del #VHC y ha actuado sobre las poblaciones de mayor riesgo (personas con conductas de riesgo sexual o por consumo de drogas).📄Desde aquí, además, se ha liderado un estudio de prevalencia y factores de riesgo de las hepatitis virales en #Cataluña mediante la realización de un registro poblacional. ¡Nuestra enhorabuena a todos!👏

[Asociación Española para el Estudio del Hígado @AEEHLiver]

📢"Modelo externalizado liderado por enfermeras para la microeliminación del virus de la #hepatitisC e impacto del perfil de consumo de drogas".
📒Estudio del nº de diciembre en 'Gastroenterología y Hepatología'.
💊Este circuito centrado en el paciente liderado por enfermeras demuestra que el tratamiento del #VHC puede administrarse exitosamente a PQID, incluso con consumo activo y complejidad socioeconómica. Consúltalo aquí:👇
https://t.co/NUpwnRA5dt

[Asociación Española para el Estudio del Hígado @AEEHLiver]

🗣️La doctora @SaSi_Lens del @hospitalclinic se centra en los avances terapéuticos en las Hepatitis Delta, B y C, con fármacos que inhiben la entrada del virus.
Comienza explicando estudios sobre uso del #Bulevertide en cohortes de pacientes con Hepatitis Delta. ¡Muy interesante!👌
#livermeeting2024

[Debbie Shawcross @DebbieShawcros1]

On 9th May I will take over as the 1st female Secretary General @EASLnews. I am looking for a partner to join me on my leadership journey and join our global hepatology platform🌎
E - Education
A - Advocacy
S - Science
L - Leadership
DM or 📞 for an informal chat.
#livertwitter